BiomX (PHGE) Accounts Payables (2018 - 2026)
BiomX (PHGE) posted Accounts Payables of $720000.0 for Q1 2026, down 76.92% sequentially from $3.1 million in Q4 2025, and down 56.89% YoY from $1.7 million in Q1 2025.
BiomX (PHGE) Accounts Payables (2018 - 2026) Analysis & Trends
BiomX has reported Accounts Payables for 9 years, with the latest figure at $720000.0 in Q1 2026.
- Quarterly Accounts Payables fell 56.89% year-over-year to $720000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $720000.0 (down 56.89% YoY) and the FY2025 annual result came in at $3.1 million, up 65.78% from the prior year.
- Accounts Payables eased to $720000.0 in Q1 2026 per PHGE's latest filing, from $3.1 million in the prior quarter.
- Over five years, Accounts Payables peaked at $5.5 million in Q3 2023 and troughed at $720000.0 in Q1 2026.
- A 5-year average of $2.4 million and a median of $2.2 million in 2022 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2026: Accounts Payables surged 209.04% in 2023, then plunged 56.89% in 2026.
- Over 5 years, Accounts Payables stood at $2.2 million in 2022, then surged by 55.53% to $3.3 million in 2023, then sank by 43.72% to $1.9 million in 2024, then soared by 65.78% to $3.1 million in 2025, then slumped by 76.92% to $720000.0 in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $720000.0, $3.1 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | BiomX | 361,408.40 | -806,591.60 | - | 720,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 720,000.00 |
| Dec 31, 2025 | 3.12 Mn |
| Sep 30, 2025 | 1.51 Mn |
| Jun 30, 2025 | 2.85 Mn |
| Mar 31, 2025 | 1.67 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Sep 30, 2024 | 2.78 Mn |
| Jun 30, 2024 | 3.02 Mn |
| Mar 15, 2024 | 2.60 Mn |
| Dec 31, 2023 | 3.34 Mn |
| Sep 30, 2023 | 5.50 Mn |
| Jun 30, 2023 | 3.39 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 2.15 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Jun 30, 2022 | 1.66 Mn |
| Mar 31, 2022 | 1.40 Mn |
| Dec 31, 2021 | 2.80 Mn |
| Sep 30, 2021 | 1.88 Mn |
| Jun 30, 2021 | 1.77 Mn |